Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Organizing pneumonia presenting after ulcerative colitis remission.

Jang EC, Choi SJ, Cho JH, Ryu JS, Kwak SM, Lee HL, Nam HS.

J Thorac Dis. 2013 Apr;5(2):E71-3. doi: 10.3978/j.issn.2072-1439.2013.03.11.

2.

Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.

Colìa R, Corrado A, Cantatore FP.

Ann Med. 2016 Dec;48(8):577-585. Epub 2016 Jun 16.

PMID:
27310096
3.

Lung disease and ulcerative colitis--mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?

Moeser A, Pletz MW, Hagel S, Kroegel C, Stallmach A.

Z Gastroenterol. 2015 Sep;53(9):1091-8. doi: 10.1055/s-0041-103377. Epub 2015 Sep 14. Review.

PMID:
26367026
4.

Pulmonary involvement: a rare extraintestinal manifestation of ulcerative colitis.

Nishikawa J, Hosokawa A, Mihara H, Hayashi R, Miwa S, Kane T, Nanjo S, Ando T, Fujinami H, Kajiura S, Minemura M, Sugiyama T.

Clin J Gastroenterol. 2014 Apr;7(2):155-8. doi: 10.1007/s12328-014-0473-7. Epub 2014 Mar 13.

PMID:
26183633
5.

Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.

Siemanowski B, Regueiro M.

Curr Treat Options Gastroenterol. 2007 Jun;10(3):178-84.

PMID:
17547856
6.

[Organizing pneumonia during treatment with mesalazine].

Michy B, Raymond S, Graffin B.

Rev Mal Respir. 2014 Jan;31(1):70-7. doi: 10.1016/j.rmr.2013.04.026. Epub 2013 Jun 18. French.

PMID:
24461446
7.

Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.

Singh B, Kedia S, Konijeti G, Mouli VP, Dhingra R, Kurrey L, Srivastava S, Pradhan R, Makharia G, Ahuja V.

Indian J Gastroenterol. 2015 Jan;34(1):43-50. doi: 10.1007/s12664-015-0538-7. Epub 2015 Feb 7.

PMID:
25663290
8.

Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis.

Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J.

Ann Surg. 1990 May;211(5):622-7; discussion 627-9.

9.

Peculiar Presentation of Ulcerative Colitis.

Ahmed HM, Diab A, Ahmed A, Abohamad S, Elgendy H.

Case Rep Gastrointest Med. 2016;2016:1763041. doi: 10.1155/2016/1763041. Epub 2016 Mar 6.

10.

Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.

Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B; EC-IBD Study Group..

Scand J Gastroenterol. 2015 Mar;50(3):300-5. doi: 10.3109/00365521.2014.991752. Epub 2014 Dec 23.

PMID:
25535653
11.

Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.

Agrawal D, Rukkannagari S, Kethu S.

Minerva Gastroenterol Dietol. 2007 Sep;53(3):233-48. Review.

PMID:
17912186
12.

Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.

Roberts H, Rai SN, Pan J, Rao JM, Keskey RC, Kanaan Z, Short EP, Mottern E, Galandiuk S.

Digestion. 2014;90(2):122-9. doi: 10.1159/000363228. Epub 2014 Oct 1.

PMID:
25277851
13.

Cutaneous manifestations in inflammatory bowel disease.

Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, Griga T.

Z Gastroenterol. 2001 Feb;39(2):137-44.

PMID:
11253504
14.

Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.

Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero-Gómez M.

J Gastroenterol Hepatol. 2014 Feb;29(2):291-5. doi: 10.1111/jgh.12352.

PMID:
23927379
15.

The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study.

Malaty HM, Abraham BP, Mehta S, Garnett EA, Ferry GD.

Clin Exp Gastroenterol. 2013 Jun 17;6:77-83. doi: 10.2147/CEG.S40259. Print 2013.

16.

Smoking increases the risk of extraintestinal manifestations in Crohn's disease.

Ott C, Takses A, Obermeier F, Schnoy E, Müller M.

World J Gastroenterol. 2014 Sep 14;20(34):12269-76. doi: 10.3748/wjg.v20.i34.12269.

17.
18.

Methotrexate for induction of remission in ulcerative colitis.

Chande N, Wang Y, MacDonald JK, McDonald JW.

Cochrane Database Syst Rev. 2014 Aug 27;(8):CD006618. doi: 10.1002/14651858.CD006618.pub3. Review.

PMID:
25162749
19.

Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.

Cañas-Ventura A, Márquez L, Ricart E, Domènech E, Gisbert JP, García-Sanchez V, Marín-Jiménez I, Rodriguez-Moranta F, Gomollón F, Calvet X, Merino O, Garcia-Planella E, Vázquez-Romero N, Esteve M, Iborra M, Gutiérrez A, Vera M, Andreu M; Spanish GETECCU group (ENEIDA project)..

J Crohns Colitis. 2014 Oct;8(10):1287-93. doi: 10.1016/j.crohns.2014.03.014. Epub 2014 Apr 13.

PMID:
24726696
20.

Lymphocytic encephalomyeloneuritis as a neurologic complication of ulcerative colitis.

Kraus JA, Nahser HC, Berlit P.

J Neurol Sci. 1996 Sep 15;141(1-2):117-9.

PMID:
8880704

Supplemental Content

Support Center